Laboratory-grown cellular matrices to replace lost tissue in severe wounds.
Healix360 supports access to advanced mobile wound care services for patients throughout our coverage area. Services are delivered by licensed physicians and nurse practitioners experienced in the evaluation and management of chronic and complex wounds. Care is coordinated and provided directly to patients in private residences, assisted living communities, and skilled nursing facilities. In wounds that have been open for months or years, the patient's own cells become senescent (exhausted) and no longer respond to normal healing signals. Applying a bioengineered cellular product introduces a massive influx of healthy, metabolically active cells (like neonatal fibroblasts), structural collagen, and vital growth factors. This powerful biological intervention essentially reboots the wound environment, signaling the patient's own tissue to rapidly close the defect.
A licensed clinician determines whether this treatment is appropriate after evaluating the wound and the patient's medical history.
Treatment decisions are individualized. Potential contraindications and precautions may include:
The application is a minor bedside procedure. Following sharp debridement to prepare a clean, vascularized wound bed, the clinician will place the bioengineered tissue directly onto the wound. It is secured with specialized non-adherent dressings and left undisturbed for a week or more. You must ensure absolute offloading and protection of the area to allow the graft to take hold.
Robust clinical trials leading to FDA approval demonstrate that bioengineered cellular therapies significantly outperform standard wound care, dramatically reducing the time to complete wound closure and significantly lowering the risk of subsequent amputation in chronic diabetic patients.
No. An autologous skin graft requires a surgeon to harvest skin from your thigh or back, creating a second painful wound. Bioengineered substitutes are grown in a lab or derived from ethical donor sources, requiring no surgical harvesting from your body.
Some advanced products contain living, metabolically active human cells (like fibroblasts) cryopreserved until application. Others are decellularized matrices that provide the structural architecture and growth factors necessary for your own cells to colonize.
No. Care is coordinated and provided directly to patients in private residences or care facilities. Our highly trained clinicians are equipped to safely prepare the wound and apply these advanced biological therapies entirely at the bedside.
While every patient responds differently, noticeable proliferation of healthy red granulation tissue and advancement of the wound edges is often observed within one to three weeks following application.
No. Bioengineered skin substitutes are FDA-approved, widely utilized in advanced wound care, and supported by extensive peer-reviewed clinical evidence. They are considered standard-of-care for refractory chronic ulcers.
Call 877-545-1300 or request a provider to begin care. Healix360 serves Southern California and Nevada and accepts Medicare Part B and most major insurance plans.